An immunotoxin with therapeutic potential in T cell leukemia: WT1-ricin A.

A conjugate of the monoclonal antibody WT1 and ricin A-chain was studied for its suitability for purging marrow of leukemic T cells for autologous transplantation in T cell acute lymphocytic leukemia (T-ALL). The conjugate was powerfully cytotoxic to the human T-ALL cell line, GH1, which expresses the WT1 antigen at a high density. Treatment of the cells with the conjugate at 10(-11) M reduced their rate of protein synthesis by 50%, and the inclusion of 6 mM ammonium chloride in the cultures enhanced the potency of cytotoxic effect by 10-100-fold. Clonogenic assays indicated that less than 0.1% of GH1 cells survived 3-hr exposure to the conjugate in ammonium chloride. WT1 alone did not react with multipotent (CFU-GEMM) hematopoietic progenitors in normal human bone marrow, as measured by fluorescence-activated cell sorting. Under conditions giving maximal killing of GH1 cells, there was no toxicity to multipotential progenitors in normal human marrow.

[1]  M. Greaves,et al.  A monoclonal antibody (WT1) for detecting leukemias of T-cell precursors (T-ALL). , 1983, Blood.

[2]  J. Uhr,et al.  Use of an antibody-ricin A-chain conjugate to delete neoplastic B cells from human bone marrow. , 1983, Blood.

[3]  R. Bast,et al.  Elimination of leukemic cells from human bone marrow using monoclonal antibody and complement. , 1983, Cancer research.

[4]  T. Lebien,et al.  In vitro cytodestruction of leukemic cells in human bone marrow using a cocktail of monoclonal antibodies. , 1983, Haematology and blood transfusion.

[5]  S. Y. Yang,et al.  Functionally different T lymphocyte subpopulations determined by their sensitivity to complement-dependent cell lysis with the monoclonal antibody 4A. , 1982, Journal of immunology.

[6]  D. Mason,et al.  Selective killing of malignant cells in a leukaemic rat bone marrow using an antibody–ricin conjugate , 1982, Nature.

[7]  J. Uhr,et al.  In vivo therapy of a murine B cell tumor (BCL1) using antibody-ricin A chain immunotoxins , 1982, The Journal of experimental medicine.

[8]  J. Uhr,et al.  Selective killing of leukaemia cells by antibody–toxin conjugates: implications for autologous bone marrow transplantation , 1982, Nature.

[9]  P. Thorpe,et al.  The Preparation and Cytotoxic Properties of Antibody‐Toxin Conjugates , 1982, Immunological reviews.

[10]  D. Mason,et al.  Elimination of leukaemic cells from rodent bone marrow in vitro with antibody-ricin conjugates: Implications for autologous marrow transplantation in man , 1982 .

[11]  B. Haynes.  Human T Lymphocyte Antigens as Defined by Monoclonal Antibodies , 1981, Immunological reviews.

[12]  E. McCulloch,et al.  A colony assay for blast cell progenitors in non-B non-T (common) acute lymphoblastic leukemia. , 1981, Blood.

[13]  A. Fauser,et al.  Identification of megakaryocytes, macrophages, and eosinophils in colonies of human bone marrow containing neurtophilic granulocytes and erythroblasts. , 1979, Blood.

[14]  R. Schweet,et al.  Synthesis of hemoglobin in a cell-free system. I. Properties of the complete system. , 1962, The Journal of biological chemistry.